Budget vs premium
MedVi vs Novi: Which Costs Less Over 12 Months? (2026)
MedVi costs $3,468 a year against $1,596 for Novi. Full 2026 comparison of price, medication class and included support.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.2 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
MedVi and Novi sit at ranks 6 and 21 in our weight loss listing, which makes them close enough to be a genuine decision rather than an obvious one.
The gap is 2.2x: $133/mo at Novi, $299/mo at MedVi. Neither number is unusual for the market, but paying the higher one only makes sense if you can name what it adds.
The sections that follow price both programs across a full course of treatment rather than a first month, then set out which patient each one is actually built for. No number here is inferred; if a provider does not publish it, the table says so.
The short answer
- Lowest 12-month cost
- Novi — $1,596 against $2,592 at MedVi, on each provider's own best published pricing.
- Most support for the money
- Novi — No long-term contract, cancel anytime.
- Tirzepatide access
- Novi — Tirzepatide at $166/mo; the other side publishes semaglutide only.
- Widest medication choice
- Novi — compounded semaglutide and compounded tirzepatide.
The short version: MedVi vs Novi
The table is built from each provider's published pricing and program detail; anything they decline to state is marked as such.
| MedVi | Novi | |
|---|---|---|
| Advertised price | $179 promotional first month | Semaglutide from $133/mo, tirzepatide from $166/mo |
| Rate after promotions | $299/mo | $133/mo |
| Pricing structure | Promotional first month, then standard rate | Published rate per medication |
| Medication | Compounded semaglutide | Compounded semaglutide and compounded tirzepatide |
| How fast you start | Simple online process, no clinic visits | Online intake |
| State coverage | Not published | Not published |
| Payment options | Card only, no financing published | Card only, no financing published |
| Membership fee | None | None |
| Patient reviews | 12,896 | 50,124 |
| eRxDoctor score | 9.2/10 | 7.0/10 |
What you will have spent by month twelve
GLP-1 treatment is not a one-month purchase, and neither of these prices it like one. So the table works in the timeframe treatment actually happens in.
| MedVi | Novi | |
|---|---|---|
| First month | $179 | $133 |
| Months 2 onward | $299/mo | $133/mo |
| 6-month total | $1,674 | $798 |
| 12-month total | $3,468 | $1,596 |
| Best published plan | 3-month plan at $649 — $2,592/yr | No multi-month discount published |
Novi finishes the year $996 cheaper. For some patients the support MedVi bundles closes that gap; for a patient who only needs the prescription written, it does not.
Price escalation to plan for: MedVi moves from $179 to $299, a 67% increase. Set a calendar reminder for the month it changes.
Where the extra money goes at MedVi
MedVi charges $299/mo where Novi charges $133/mo. A premium is defensible only if it maps to something specific, so here is what MedVi puts behind it: 24/7 support from certified medical professionals, and fast, free shipping.
Novi's answer is the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166. What it does not carry: the $133 rate depends on a $200-off promotion and there is no outcome guarantee.
The premium buys attention. If you expect to need it — first GLP-1, side effects you will want triaged quickly, a history of stalling around week ten — it is money well spent. If you do not, it is not.
Inside the MedVi program
MedVi provides compounded semaglutide starting at $179/month with a simple online intake, no clinic visits, and 24/7 certified medical support for weight loss. What it is really selling here is a genuinely low promotional entry point with 24/7 clinical support behind it.
Practically: simple online process, no clinic visits, fast, free shipping, and a pricing model that is promotional first month, then standard rate.
24/7 support from certified medical professionals. The formulary covers compounded semaglutide.
MedVi pros
- 24/7 support from certified medical professionals
- Simple online process with no clinic visits required
- Low promotional first month at $179 including fast, free shipping
- Clinically dosed compounded semaglutide
MedVi cons
- No published outcome or weight loss guarantee
- Compounded medication only, no branded Ozempic or Wegovy
- Semaglutide only, no tirzepatide option
Where it gives ground to Novi: the price roughly doubles to $299 once the promotional month ends.
Novi: what you are buying
$200 OFF - GLP-1 for $133 Today Against MedVi, that puts it in the position of the cheaper option.
Intake is online intake. Fulfillment is free 2-day shipping with every order. The commercial terms are published rate per medication, published upfront.
Support: no long-term contract, cancel anytime. The medications on offer are compounded semaglutide and compounded tirzepatide.
Novi pros
- Both compounded semaglutide and tirzepatide available
- Free 2-day shipping included with every order
- Competitive pricing: semaglutide from $133/month and tirzepatide from $166/month
- Largest patient base on this list, 50,000+ patients, signaling operational maturity
Novi cons
- No published outcome or weight loss guarantee
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Tirzepatide ($166) costs more than the semaglutide entry rate
Read next to MedVi, the weak point: the $133 rate depends on a $200-off promotion and there is no outcome guarantee.
Picking between them
Choose MedVi if:
- delivery works the way you want it to: fast, free shipping
- you want to start on their timeline: simple online process, no clinic visits
- the level of clinical contact suits you: 24/7 support from certified medical professionals
- you would get real value from a genuinely low promotional entry point with 24/7 clinical support behind it
Choose Novi if:
- the twelve-month total is what you are optimizing ($1,596 against $3,468)
- you would get real value from the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166
- the monthly rate is the constraint — $133/mo against $299/mo
- you want tirzepatide available without changing provider later
The compromises on both sides
On price. The monthly gap is 2.2x in Novi's favor. Whether that is a saving or a false economy turns on one thing: the $133 rate depends on a $200-off promotion and there is no outcome guarantee.
On commitment. MedVi rewards a longer commitment (3-month plan at $649), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On access. MedVi advertises simple online process, no clinic visits and fast, free shipping; Novi advertises online intake and free 2-day shipping with every order. Neither publishes its state coverage, so confirm you are eligible before paying for anything.
On predictability. Promotional first month, then standard rate versus published rate per medication. Whichever you pick, get the maintenance-dose price in writing at intake.
What the evidence actually says
Before either program's marketing claims, the underlying evidence — which belongs to the medication, not the platform.
Compounding is lawful within a specific statutory framework, and the conditions attached to it have changed as GLP-1 shortages have resolved, per FDA.
Compounded drugs are not FDA-approved, and the agency does not verify their safety, effectiveness or quality before they reach a patient, per FDA.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
MedVi vs Novi: common questions
What happens when MedVi's promotional price ends?
The rate moves to $299/mo, a 67% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Which is cheaper to start, MedVi or Novi?
Novi, at $133 against $179. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Is Novi cheaper than MedVi?
Yes, on the ongoing rate. Novi runs $133/mo once promotional pricing ends, against $299/mo at MedVi — a difference of 2.2x. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Which costs less over a year, MedVi or Novi?
Novi, at roughly $1,596 for twelve months against $2,592 at MedVi, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Which has more patient reviews, MedVi or Novi?
Novi, with 50,124 against 12,896. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do MedVi or Novi take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
How fast can I start with MedVi compared with Novi?
MedVi advertises simple online process, no clinic visits, with fast, free shipping. Novi advertises online intake, with free 2-day shipping with every order. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
The verdict
Strictly on cost, Novi takes it — $1,596 to $2,592 over twelve months.
MedVi earns the difference in one situation: when a genuinely low promotional entry point with 24/7 clinical support behind it is something you will genuinely use. If you cannot say that out loud, take the cheaper program.
Whichever way you go, the medication is the same class of drug and the clinical questions belong to a clinician. What you are choosing here is a billing model and a support structure.
Keep comparing
- MedVi vs LIV BodyLocked price vs escalating price
- MedVi vs Mochi HealthBudget vs premium
- Novi vs Mochi HealthTirzepatide access
- LIV Body vs NoviBudget vs premium
- TrimRx vs Start WillowBudget vs premium
- TrimRx vs EmbodyBudget vs premium
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by MedVi or Novi, and does not sell treatment. Read our ranking methodology.